Donor lymphocyte infusion for late relapse followed by kidney transplantation for end-stage renal failure after allogeneic bone marrow transplantation for chronic myeloid leukemia.
Baron, Frédéric ; Centre Hospitalier Universitaire de Liège - CHU > Hématologie clinique
Chachati, Alfred
Bury, Jean
Morelon, Emmanuel
Kreis, Henri
BEGUIN, Yves ; Centre Hospitalier Universitaire de Liège - CHU > Hématologie clinique
Language :
English
Title :
Donor lymphocyte infusion for late relapse followed by kidney transplantation for end-stage renal failure after allogeneic bone marrow transplantation for chronic myeloid leukemia.
Publication date :
2003
Journal title :
Transplantation
ISSN :
0041-1337
eISSN :
1534-6080
Publisher :
Lippincott Williams & Wilkins, Hagerstown, United States - Maryland
Cohen EP, Piering WF, Kabler-Babbitt C, et al. End-stage renal disease (ESRD) after bone marrow transplantation: Poor survival compared to other causes of ESRD. Nephron 1998; 79: 408-412.
Helg C, Chapuis B, Bolle JF, et al. Renal transplantation without immunosuppression in a host with tolerance induced by allogeneic bone marrow transplantation. Transplantation 1994; 58: 1420-1422.
Dey B, Sykes M, Spitzer TR. Outcomes of recipients of both bone marrow and solid organ transplants: A review. Medicine (Baltimore) 1998; 77: 355-369.
Sellers MT, Deierhoi MH, Curtis JJ, et al. Tolerance in renal transplantation after allogeneic bone marrow transplantation: 6-year follow-up. Transplantation 2001; 71: 1681-1683.
Baron F, Beguin Y. Adoptive immunotherapy with donor lymphocyte infusions after allogeneic HPC transplantation. Transfusion 2000; 40: 468-476.
